GastroAGI Logo
OverviewBlogsAbout
Trending TopicsDaily BriefConference
Topics/Cirrhosis Liver/Nutrition in Cirrhosis - Hepatology Dec 2025
38

Nutrition in Cirrhosis - Hepatology Dec 2025

Clinical knowledge base written and curated by GastroAGI Team from primary medical literatureLast updated February 1, 2026

Nutrition in Cirrhosis and Liver Transplantation:

Cirrhosis is a condition characterized by severe liver dysfunction, often leading to malnutrition, sarcopenia (low muscle mass), and physical frailty. These conditions are prevalent in patients with cirrhosis, affecting 20%–80% of patients with malnutrition, 30%–70% with sarcopenia, and 17%–43% with frailty. Malnutrition and sarcopenia are significant risk factors for poor outcomes, as they reduce functional capacity, impair recovery, and increase the risk of complications both pre- and post-transplant.

Key Aspects of Nutrition in Cirrhosis:

  1. Nutritional Assessment:
  • It is critical to assess the nutritional status of patients with cirrhosis to identify malnutrition, sarcopenia, and frailty.
  • Tools and guidelines should be used to evaluate body composition, muscle mass, and dietary intake.
  1. Nutritional Intervention:
  • Nutritional prehabilitation is essential for patients awaiting LT. This involves optimizing energy intake, protein consumption, and addressing any deficiencies.
  • Protein intake is particularly important, as it supports muscle health and combats sarcopenia. Recommendations include distributing protein intake evenly throughout the day and ensuring high-quality protein sources.
  • Adequate energy intake tailored to the patient's body mass index (BMI) is necessary to meet their metabolic demands.
  • Carbohydrate and fat intake should also be balanced to provide sufficient energy while avoiding complications such as hyperglycemia.
  1. Reassessment and Monitoring:
  • Regular follow-up is critical to monitor progress and adjust nutritional interventions as needed.
  • This approach ensures that nutritional strategies remain effective and aligned with the patient's evolving needs.

Importance of Nutrition in Cirrhosis:

  • Proper nutrition can enhance the patient's physiological reserve, improve functional capacity, and reduce the risk of complications during and after LT.
  • Malnutrition and sarcopenia, if left unaddressed, can impair the patient's ability to recover from surgery, increase the risk of infections, and prolong hospital stays.

Summary:

Malnutrition, sarcopenia, and frailty are common in patients with cirrhosis awaiting liver transplantation (LT), significantly impacting postoperative outcomes. Nutritional prehabilitation, a key pillar of multidimensional prehabilitation, involves assessing nutritional status, implementing targeted interventions, and regularly reassessing progress. Recommendations emphasize adequate energy intake, high-quality protein distribution, and addressing deficiencies to improve muscle health and functional capacity. Despite its importance, nutrition in LT prehabilitation remains understudied, with future research needed to refine energy needs, explore dietary supplements, and optimize interventions. Current guidelines advocate proactive nutritional strategies to transform the LT waitlist period into an opportunity for functional improvement.

Related Q&A

39

Human Albumin Solutions in Cirrhosis liver - Hept.Comm. Feb.2026

Human Albumin Solutions (HAS): Human Albumin Solution (HAS) is a sterile, purified preparation of human serum albumin, a protein derived from plasma. Albumin plays a critical role in...

40

Acute-on-Chronic Liver Failure: Pathophysiology and Management

Acute-on-Chronic Liver Failure (ACLF) is a distinct clinical syndrome characterized by the rapid deterioration of liver function in patients with pre-existing chronic liver disease or cirrhosis. This condition...

41

Plasma exchange and Survival- real world data

The real-world data on plasma exchange (PEX) in the context of acute liver failure (ALF) suggests that while PEX may provide certain physiological and clinical benefits, it does...

42

Peripheral Venous Access for Low-Volume Plasma Exchange in Liver Disease

Peripheral venous access for low-volume plasma exchange (PLEX) in liver disease represents a promising approach to address the challenges associated with central venous catheterization, particularly in patients with...

43

Noninvasive Markers of Portal Hypertension and Varices in Noncirrhotic Disease

Noncirrhotic portal hypertension (NCPH) encompasses a range of disorders affecting the hepatic portosinusoidal vascular system, leading to portal hypertension (PH). Unlike cirrhosis, there are no established noninvasive criteria...

44

VanC-IT: A Phase 2 Randomized Trial of Oral Vancomycin in Primary Sclerosing Cholangitis

The VanC-IT trial is a phase 2 clinical study designed to evaluate the efficacy and safety of oral vancomycin in patients with primary sclerosing cholangitis (PSC), a chronic...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersSoonFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer